Michael A Ihnat

University Of Oklahoma Hlth Sciences Ctr

$2,710,293

Attributed

$2,710,293

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.1M · FY2005–21

$2M$1.5M$1M$500K$0

'05

'06

'07

'08

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

'21

Funding mix

By agency

NIH$2,710,293 · 6

By mechanism

R44$1,974,199 · 1

P20$468,644 · 3

R03$145,000 · 1

R43$122,450 · 1

Top collaborators

No co-investigators on record.

Most similar at University Of Oklahoma Hlth Sciences Ctr

Same institution · by research overlap

John D. Ash$9,888,238
Michael H Elliott$7,932,578
Yun Z Le$4,829,010
Raju Vs Rajala$11,942,912
Sarah X Zhang$9,089,188

Others in their field

Top investigators on “In Vivo”

David Heimbrook · Leidos Biomedical Research, Inc.$371,850,582
Leonard Freedman · Leidos Biomedical Research, Inc.$304,459,298
Dennis R. Burton · Scripps Research Institute$212,708,174
Mark S Klempner · Tufts Medical Center$128,021,180
Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
David M. Margolis · University Of Texas Sw Med Ctr/Dallas$98,374,200

Research focus

In VivoMalignant NeoplasmsDoseToxic EffectMouse ModelNeoplastic CellRecurrenceKillingsLiverLegal PatentMammary NeoplasmsMicrometastasisAngiogenesisNeoplasm MetastasisCytotoxicDoxorubicinCellsCancer CellExtracellular MatrixCessation Of LifeLeadBladderDrug Delivery SystemsLung